‘We simply don’t yet know enough’: International commission urges caution with human germline editing
‘We simply don’t yet know enough’: International commission urges caution with human germline editing
‘We simply don’t yet know enough’: International commission urges caution with human germline editing
We’re unlikely to cure Alzheimer’s with CRISPR. But the gene-editing tool could play a crucial role.
Viewpoint: Our favorite Cavendish banana may be heading towards extinction—Scientists say only a biotech solution, blocked by anti-GMO activists, can save it
Viewpoint: How anti-GMO activism keeps disease-resistant bananas off the market—and what we can do about it
Viewpoint: Why the Non-GMO Project label is little more than a marketing tool that deceives consumers
Following approval of GMO crops, Nigeria sets sights on other biotech advances, including gene editing and synthetic biology
Podcast: Francis Galton: Brilliant scientist—and eugenics pioneer. How do we address his racist legacy?
Viewpoint: Why science hasn’t given us a cure for cancer: We’re still ‘trying to understand it’
Podcast: Has sickle cell disease met its match in CRISPR gene editing?
Podcast: Has sickle cell disease met its match in CRISPR gene editing? Read More »
How a one-time CRISPR shot could obliterate lower back pain
How a one-time CRISPR shot could obliterate lower back pain Read More »